miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma-Reference-Cited by-同舟云学术

miR-3941: A novel microRNA that controls IGBP1 expression and is associated with malignant progression of lung adenocarcinoma

Published:2017-03 Issue:3 Volume:108 Page:536-542
ISSN:1347-9032
Container-title:Cancer Science
language:en
Short-container-title:Cancer Sci

Author:

Sato Taiki¹,Shiba-Ishii Aya²,Kim Yunjung¹,Dai Tomoko¹,Husni Ryan Edbert¹,Hong JeongMin¹,Kano Junko²,Sakashita Shingo²,Iijima Tatsuo³,Noguchi Masayuki²

Affiliation:

1. Department of Pathology; Graduate School of Comprehensive Human Sciences; University of Tsukuba; Tsukuba-shi Ibaraki Japan

2. Department of Pathology; Faculty of Medicine; University of Tsukuba; Tsukuba-shi Ibaraki Japan

3. Department of Pathology; Ibaraki Prefectural Central Hospital; Kasama-shi Ibaraki Japan

Funder

Japan Society for the Promotion of Science

Publisher

Wiley

Subject

Cancer Research,Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/cas.13148/fullpdf

Reference44 articles.

1. The International Epidemiology of Lung Cancer: geographical distribution and secular trends;Youlden;J Thorac Oncol,2008

2. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

3. Small adenocarcinoma of the lung. Histologic characteristics and prognosis;Noguchi;Cancer,1995

4. Prognostication of small-sized primary pulmonary adenocarcinomas by histopathological and karyometric analysis;Minami;Lung Cancer,2005

5. IASLC/ATS/ERS international multidisciplinary classification of lung adenocarcinoma;Travis;J Thorac Oncol,2011

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MicroRNA‑mediated regulation in lung adenocarcinoma: Signaling pathways and potential therapeutic implications (Review);Oncology Reports;2023-10-18

2. MiRNAs in Lung Adenocarcinoma: Role, Diagnosis, Prognosis, and Therapy;International Journal of Molecular Sciences;2023-08-27

3. Hsa-miR-181a-5p, hsa-miR-182-5p, and hsa-miR-26a-5p as potential biomarkers for BCR-ABL1 among adult chronic myeloid leukemia treated with tyrosine kinase inhibitors at the molecular response;BMC Cancer;2022-03-26

4. Development of multi-epitope vaccine constructs for non-small cell lung cancer (NSCLC) against USA human leukocyte antigen background: an immunoinformatic approach toward future vaccine designing;Expert Opinion on Biological Therapy;2021-09-29

5. MiR-196b Promotes the Invasion and Migration of Lung Adenocarcinoma Cells by Targeting AQP4;Technology in Cancer Research & Treatment;2021-01-01